New Development in Exchanges between USST and Enterprises

On the morning of April 10th, Dai Minmin, vice president of Shanghai Guosheng Co., Ltd, Chen Feili, manager of Investment Department Ⅰ of Shanghai Lianhe Investment Co., Ltd, and Qin Xi, president of Shanghai Simic Holdings Co., Ltd paid a visit to our school.
USST president Ding Xiaodong extended a warm welcome. He pointed out that under new post-COVID-19 circumstances, with a view of meeting national strategic demands and facilitating local economic development, USST made plans and took actions. He cited examples to talk about the “One Health” policy issued by the National Development and Reform Commission and the Ministry of Science and Technology. It will sustain biomedical security technology, and encourage scientific research institutes, universities and corporations to establish new research institutions, joint laboratories, which will also be an important part of the university’s 14th Five-year Development Plan. USST will take advantage of its disciplinary strength and talents advantage to play an active part in society. Vice president of USST Liu Ping gave an introduction about USST’s and SHSMU (Shanghai Jiao Tong University School of Medicine)’s superior disciplinary foundation, critical medical-engineering areas and the latest development of medical-engineering project, and gave advice about the path to project industrialization.
Dai Minmin pointed out that the development of medical-engineering interdisciplinary research agrees with social development. She hopes that USST can work together with Shanghai Jiao Tong University School of Medicine to serve society through an interdisciplinary medical-engineering platform. Chen Feili applauds the prominent achievements about medical-engineering interdisciplinary work, and expects that by cooperating with universities, and following the concept of “Creativity, Innovation, Development, Industrialization”, Shanghai Guosheng Co., Ltd plays an active part in transferring medical-engineering achievements into products. Both sides carried out an in-depth communication about the next concrete approaches to it.
Wu Jianyong, secretary of Party Committee of USST, put that relying on scientific foundation of USST and clinical medical technology of Shanghai Jiao Tong University School of Medicine, the medical-engineering cooperation in clinical demands, R&D of products between USST and SHSMU achieves remarkable effects. By cooperating with companies with rich experience in project investment such as Shanghai Guosheng Co., Ltd and Shanghai Lianhe Investment Co., Ltd, USST can strengthen and complete the industrial chain of medical device transfer. He hopes that the cooperation can maximize the medical-engineering industrial platform, implement the policy of “Article 25 of Shanghai Science and Technology Reform”, and achieve an integrated and high-quality industry-university-research development.